|
1
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ingelsson E, Schaefer EJ, Contois JH,
McNamara JR, Sullivan L, Keyes MJ, et al: Clinical utility of
different lipid measures for prediction of heart disease in men and
women. JAMA. 298:776–785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siasos G, Tousoulis D, Oikonomou E,
Zaromitidou M, Stefanadis C and Papavassiliou AG: Inflammatory
markers in hyperlipidemia: from experimental models to clinical
practice. Curr Pharm Des. 17:4132–4146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, Bloom O, Zhang M, Vishnubhakat JM,
Ombrellino M, Che J, et al: HMG-1 as a late mediator of endotoxin
lethality in mice. Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Scaffidi P, Misteli T and Bianchi ME:
Release of chromatin protein HMGB1 by necrotic cells triggers
inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q,
Zhang RY, et al: Increased serum HMGB1 level is associated with
coronary artery disease in nondiabetic and type 2 diabetic
patients. Atherosclerosis. 205:544–548. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu X, Jiang H, Bai Q, Zhou X, Xu C, Lu Z,
et al: Increased serum HMGB1 is related to the severity of coronary
artery stenosis. Clin Chim Acta. 406:139–142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding HS and Yang J: High mobility group
box-1 and cardiovascular diseases. Saudi Med J. 31:486–489.
2010.PubMed/NCBI
|
|
10
|
Kohno T, Anzai T, Naito K, Miyasho T,
Okamoto K, Yokota H, et al: Role of high-mobility group box 1
protein in post-infarction healing process and left ventricular
remodelling. Cardiovasc Res. 81:565–573. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haraba R, Suica VI, Uyy E, Ivan L and
Antohe F: Hyperlipidemia stimulates the extracellular release of
the nuclear high mobility group box 1 protein. Cell Tissue Res.
346:361–368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalinina N, Agrotis A, Antropova Y,
DiVitto G, Kanellakis P, Kostolias G, et al: Increased expression
of the DNA binding cytokine HMGB1 in human atherosclerotic lesions.
Arterioscler Thromb Vasc Biol. 24:2320–2325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inoue K, Kawahara KI, Krishna K, Ando K,
Mitsudo K, Nobuyoshi M and Maruyama I: HMGB1 expression by
activated vascular smooth muscle cells in advanced human
atherosclerosis plaques. Cardiovasc Pathol. 16:136–143. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niccoli G, Biasucci LM, Biscione, Fusco B,
Porto I, Leone AM, et al: Independent prognostic value of
C-reactive protein and coronary artery disease extent in patients
affected by unstable angina. Atherosclerosis. 196:779–785. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Arroyo-Espliguero R, Avanzas P, Quiles J
and Kaski JC: Predictive value of coronary artery stenoses and
C-reactive protein levels in patients with stable coronary artery
disease. Atherosclerosis. 204:239–243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Musial J, Undas A, Gajewski P, Jankowski
M, Sydor W and Szczeklik A: Anti-inflammatory effects of
simvastatin in subjects with hypercholesterolemia. Int J Cardiol.
77:247–253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ascer E, Bertolami MC, Venturinelli ML,
Buccheri V, Souza J, Nicolau JC, et al: Atorvastatin reduces
proinflammatory markers in hypercholesterolemic patients.
Atherosclerosis. 177:161–166. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu X, Fu W and Jiang H: HMGB1: A potential
therapeutic target for myocardial ischemia and reperfusion injury.
Int J Cardiol. 155:489. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Zhang X, Liu L, Yang R, Cui L and
Li M: Atorvastatin protects rat brains against permanent focal
ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4),
NF-kappaB expression. Neurosci Lett. 471:152–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang J, Huang C, Yang J, Jiang H and Ding
J: Statins attenuate high mobility group box-1 protein-induced
vascular endothelial activation: a key role for TLR4/NF-κB
signaling pathway. Mol Cell Biochem. 345:189–195. 2010.PubMed/NCBI
|
|
21
|
Blumenthal RS and Boltlmore MD: Statins:
effective antiathero-sclerotic therapy. Am Heart J. 139:577–583.
2000. View Article : Google Scholar : PubMed/NCBI
|
